Macon Pradaxa Lawsuits
Pradaxa (dabigatran) was approved by the FDA in 2010 and was quickly found to have possibly caused a multitude of serious, possibly life-threatening injuries. The Pradaxa Internal Bleeding Class Action Lawsuit Investigation is actively researching claims from consumers who were possibly injured by Pradaxa.
If you or a loved one experienced any of the following complications after taking Pradaxa, you may have a legal claim:
- Internal bleeding
- Kidney bleeding
- Gastrointestinal bleeding
- Heart attack
- Brain hemorrhage
Pradaxa (dabigatran) is a relatively new anticoagulant drug manufactured by Boehringer Ingelheim Pharmaceuticals. Pradaxa is in a class of drugs called Direct Thrombin Inhibitors, also known as blood thinners or anticoagulants. It was approved by the FDA in October of 2010 as an anticoagulant drug that was superior to the prescription drug Coumadin (warfarin) because it allegedly required less monitoring of the patient and very little change of diet. Very quickly it was found that the Pradaxa users who experienced internal bleeding while taking the drug were at a disadvantage compared to those on Coumadin (warfarin). Coumadin patients who experienced abdominal bleeding could counteract those side effects by flushing their body with Vitamin K, which allows their blood to clot normally once again, stopping internal bleeding. There is was no such solution available for Pradaxa patients. .
Within the first year, there were more than 260 reported deaths allegedly from Pradaxa due to internal bleeding, gastrointestinal bleeding, hemorrhage and stroke. Pradaxa side effect lawsuits allege that the problem with Pradaxa is that once a hemorrhage or internal bleed starts there is no way to stop the bleed until the body is flushed of Pradaxa by dialysis. This may take hours and result in multiple blood transfusions for the patient, or their death.
In December 2011, the FDA (U.S. Food and Drug Administration) issued a warning notifying users of Pradaxa of the serious risk of uncontrollable internal bleeding which may be attributed to the use of Pradaxa. Pradaxa lawsuits allege that Boehringer Ingelheim knew of the severe side effects of Pradaxa but didn’t notify patients, or their prescribing physicians, of the risk of internal bleeding, hemorrhage, and death while taking Pradaxa.
More About: Dangerous Medications